Hardman & Co

Diurnal Group Flow of regulatory approvals

Diurnal Group plc (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its products are targeting rare conditions where medical need is currently unmet, with

Hardman & Co

Allergy Therapeutics Record sales and a COVID-19 wildcard

Allergy Therapeutics plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. Pollinex Quattro (PQ) is an ultra-short-course subcutaneous allergy immunotherapy (SCIT) platform, which continues to

Hardman & Co

Palace Capital Encouraging full-year results

The healthy liquidity position of Palace Capital plc (LON:PCA) takes risks down to a modest level, as does the overweight to regional offices and minimal shops. The Hudson Quarter mixed-development

Hardman & Co

B-North: Bridge over troubled waters

In this note, we review B-North’s core competitive advantages. We consider how the COVID-19 crisis has i) affected the competitive environment, if anything improving the long-term outlook, ii) affected operational

Hardman & Co

Incanthera preparing Sol for commercialisation

Incanthera plc (NEX:INC) is a spin-out from the Institute of Cancer Therapeutics (ICT) at the University of Bradford to exploit development opportunities generated by ICT. This has provided the company

Hercules Site Services plc
Hercules Site Services plc (LON:HERC) CEO Brusk Korkmaz & CFO Paul Wheatcroft discuss 2024 highlights & share exciting plans for 2025
Ilika plc
Ilika plc CEO Graeme Purdy discusses the successful commissioning of Stereax batteries at Cirtec, product qualification, customer interest, and future news to monitor.
STRIX GROUP PLC ORD 1P
Strix Group plc CEO Mark Bartlett discusses the company's focus on safety controls, global reach, innovation, and growth opportunities for investors.
Firering Strategic MineralS PLC
Learn about Firering Strategic Minerals plc's operations and future plans from an exclusive interview with their Independent Non-Executive Director, Vassilios Carellas.
Pulsar Helium Inc
Discover insights into the helium sector as Stephane Foucard delves into the projects of junior companies, assessing key criteria for commercial viability.
Fidelity Japan Trust
The Nikkei 225 shows resilience despite market challenges, with key sectors driving select stocks higher. Find out more about the market dynamics here.
Fidelity Emerging Markets
Emerging markets show renewed strength amid US policy shifts and positive regional indicators, sparking investor interest in their growth potential.
Fidelity International
Kepler Partners' Investment Trust Research Analyst discusses Fidelity Japan Trust plc with DirectorsTalk, highlighting its unique investment strategy and market views.
Fidelity European Trust
European markets are resilient with Stoxx 600 climbing 0.5%, despite concerns over bond yields. Fidelity European Trust PLC offers European exposure for long-term investors.
Fidelity Special Values
London's equity markets remain resilient amid positive momentum in Europe as investors react to potential US tariff approach. FTSE 100 sees modest gains.
Fidelity China Special Situations
China's stock markets rally as regulatory support boosts investor confidence. Local chip companies soar amid US export curbs. Find out more here.